TOMI Environmental Solutions Selected by NASA for Biosecurity Operation

Rhea-AI Summary

TOMI Environmental Solutions (NASDAQ: TOMZ) has announced the deployment of its SteraMist iHP technology at the NASA Johnson Space Center, marking its entry into the aerospace sector. The technology, developed through DARPA, will be used in a biosafety cabinet for handling Mars Perseverance Rover mission samples.

The deployment, facilitated through TOMI's distributor ARES Distribution, is in the final qualification process and has shown promising results in meeting NASA's planetary protection requirements. This initiative is part of TOMI's SteraMistX campaign, which focuses on aerospace, military, and exploration fields.

The company's Binary Ionization Technology® (BIT™) platform uses a low percentage hydrogen peroxide as its active ingredient and employs patented ionized Hydrogen Peroxide (iHP™) technology in all SteraMist systems for superior disinfection.

Positive

• Secured contract with NASA for Mars mission sample handling
• Successfully expanded into aerospace sector
• Technology meets NASA's stringent planetary protection requirements
• Partnership with government and commercial services engineering contractor

Negative

• None.

Insights

Financial Analyst

TOMI Environmental Solutions' NASA partnership represents a significant validation milestone for this micro-cap company. With a market capitalization of just $15.6 million, securing NASA as a client delivers substantial credibility for TOMI's disinfection technology in highly regulated environments.

The selection of SteraMist for the Mars Perseverance Rover sample handling at Johnson Space Center demonstrates the technology's effectiveness in meeting extreme biosecurity requirements. This aerospace sector expansion aligns strategically with the company's SteraMistX campaign targeting high-value sectors including military applications.

While financial terms remain undisclosed, making immediate revenue impact assessment difficult, the reputational benefit could prove valuable for future business development. For micro-cap companies, securing prestigious government contracts often serves as a catalyst for additional business opportunities and potential valuation re-rating.

The "final qualification process" status suggests commercial deployment is imminent rather than speculative. This relationship positions TOMI to potentially capture additional aerospace and defense contracts, where contamination control requirements are stringent and solutions command premium pricing. For a company of TOMI's size, establishing a foothold in a new vertical with a prestigious anchor client represents a material business development.

Defense Technology Specialist

NASA's selection of TOMI's SteraMist technology for Mars sample handling highlights the solution's exceptional capabilities in critical contamination control scenarios. The planetary protection protocols for extraterrestrial sample handling represent some of the most stringent biosecurity requirements in existence - contamination is simply not an option when dealing with potential extraterrestrial materials.

The technology's origins through DARPA funding and subsequent NASA adoption creates a powerful reference case. Government agencies and defense contractors typically require extensive validation before deployment, particularly for mission-critical applications like space exploration. This suggests SteraMist has passed extraordinarily high performance thresholds.

Partnership with a government engineering contractor (unnamed in the release) adds another layer of validation, as these firms typically conduct rigorous competitive assessments before recommending technologies. The biosafety cabinet application specifically for Mars samples represents a high-visibility use case.

The aerospace sector presents meaningful growth potential for advanced decontamination technologies, particularly as private space exploration and satellite deployment accelerate. By establishing credentials in NASA's exacting environment, TOMI positions itself advantageously for the emerging commercial space economy where contamination control remains paramount for both Earth-to-space and space-to-Earth transfer scenarios.

FREDERICK, Md., March 20, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions developed through DARPA technology, today announced the deployment of its SteraMist iHP technology at the NASA Johnson Space Center, marking the Company’s expansion into the aerospace sector.

TOMI’s SteraMist iHP technology has been selected by NASA in partnership with a U.S. government and commercial services engineering contractor dedicated to mission and defense solutions, including space exploration and scientific discovery. SteraMist iHP is now being utilized in a biosafety cabinet designated for handling samples returned from the Mars Perseverance Rover mission at the NASA Johnson Space Center.

This opportunity, facilitated through TOMI’s distributor ARES Distribution, is in the final qualification process and has already demonstrated promising results in meeting NASA's stringent requirements for planetary protection.

This successful deployment marks a significant advancement for SteraMist iHP technology, showcasing its potential for broader applications within the aerospace sector and beyond. This strategic partnership aligns with the Company’s ongoing SteraMistX campaign, which focuses on aerospace, military, and exploration fields utilizing iHP decontamination to elevate biosecurity biosafety standards.

"We are incredibly proud and excited to have our SteraMist iHP technology selected by NASA for such a critical mission," said Dr. Halden Shane, CEO of TOMI Environmental Solutions. "This collaboration not only underscores the efficacy of our solutions in addressing the unique challenges of planetary protection but also highlights our commitment and those of our partners to advancing biosecurity in innovative and growing fields like aerospace and space exploration."

TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®

TOMI™ Environmental Solutions, Inc. (NASDAQ: TOMZ ) is a global decontamination and infection prevention company, providing environmental solutions for disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage hydrogen peroxide as its only active ingredient and uses patented ionized Hydrogen Peroxide (iHP™) technology in all SteraMist systems to create superior disinfection. TOMI products are designed to service a broad spectrum of use sites, including, but not limited to, hospitals and medical facilities, biosafety labs, pharmaceutical facilities, commercial and office buildings, schools, restaurants, meat and produce processing facilities, and police and fire departments.

For additional information, please visit http://www.steramist.com or contact us at info@tomimist.com

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, statements relating to TOMI’s products to serve aerospace and space exploration markets and partnership with NASA and government contractors. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.

INVESTOR RELATIONS CONTACT:
John Nesbett/Rosalyn Christian
IMS Investor Relations
tomi@imsinvestorrelations.com

FAQ

What is TOMI's new contract with NASA for the Mars Perseverance mission?

TOMI's SteraMist iHP technology will be used in a biosafety cabinet at NASA Johnson Space Center for handling Mars Perseverance Rover mission samples.

How does TOMI's SteraMist technology work for space applications?

SteraMist uses Binary Ionization Technology with low percentage hydrogen peroxide and patented iHP technology for superior disinfection and decontamination.

What is the current status of TOMZ's NASA deployment project?

The deployment is in the final qualification process and has demonstrated promising results in meeting NASA's planetary protection requirements.

How does the NASA partnership align with TOMI's business strategy?

The partnership aligns with TOMI's SteraMistX campaign, focusing on expanding into aerospace, military, and exploration fields for biosecurity applications.

What market expansion does this NASA contract represent for TOMZ stock?

This contract represents TOMI's expansion into the aerospace sector, opening new opportunities beyond their traditional markets in healthcare and commercial facilities.